Catalent
CTLT
#1737
Rank
โ‚น1.035 T
Marketcap
โ‚น5,703
Share price
0.00%
Change (1 day)
20.71%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total assets

Total assets on the balance sheet as of September 2024 : โ‚น872.13 Billion

According to Catalent's latest financial reports the company's total assets are โ‚น872.13 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Catalent - Total assets on balance sheet (from 2013 to 2024)

Total assets by year

Year Total assets Change
2023-06-30โ‚น884.36 B6.58%
2022-06-30โ‚น829.74 B22.44%
2021-06-30โ‚น677.66 B15.03%
2020-06-30โ‚น589.10 B38.18%
2019-06-30โ‚น426.32 B37.47%
2018-06-30โ‚น310.13 B38.94%
2017-06-30โ‚น223.21 B6.98%
2016-06-30โ‚น208.65 B4.55%
2015-06-30โ‚น199.56 B7.69%
2014-06-30โ‚น185.31 B5.55%
2013-06-30โ‚น175.57 B0.76%
2012-06-30โ‚น174.24 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Supernus Pharmaceuticals
SUPN
โ‚น127.54 B-85.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚น33.74 B-96.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
โ‚น1.020 T 16.98%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
โ‚น35.32 B-95.95%๐Ÿ‡บ๐Ÿ‡ธ USA